Bioavailability of pyridoxal phosphate from enteric-coated tablets. III. Correlations between bioavailability in humans and beagle dogs and between bioavailability in humans and in vitro dissolution rates. 1985

N Kaniwa, and H Ogata, and N Aoyagi, and M Koibuchi, and T Shibazaki, and A Ejima, and S Takanashi, and H Kamiyama, and H Suzuki, and Y Hinohara

UI MeSH Term Description Entries
D008297 Male Males
D011732 Pyridoxal Phosphate This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE). Pyridoxal 5-Phosphate,Pyridoxal-P,Phosphate, Pyridoxal,Pyridoxal 5 Phosphate,Pyridoxal P
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013608 Tablets, Enteric-Coated Tablets coated with material that delays release of the medication until after they leave the stomach. (Dorland, 28th ed) Enteric-Coated Tablets,Tablets, Enteric Coated

Related Publications

N Kaniwa, and H Ogata, and N Aoyagi, and M Koibuchi, and T Shibazaki, and A Ejima, and S Takanashi, and H Kamiyama, and H Suzuki, and Y Hinohara
August 1984, Journal of pharmacokinetics and biopharmaceutics,
N Kaniwa, and H Ogata, and N Aoyagi, and M Koibuchi, and T Shibazaki, and A Ejima, and S Takanashi, and H Kamiyama, and H Suzuki, and Y Hinohara
June 1990, Journal of veterinary pharmacology and therapeutics,
N Kaniwa, and H Ogata, and N Aoyagi, and M Koibuchi, and T Shibazaki, and A Ejima, and S Takanashi, and H Kamiyama, and H Suzuki, and Y Hinohara
January 1982, The Journal of pharmacy and pharmacology,
N Kaniwa, and H Ogata, and N Aoyagi, and M Koibuchi, and T Shibazaki, and A Ejima, and S Takanashi, and H Kamiyama, and H Suzuki, and Y Hinohara
June 1973, Lancet (London, England),
N Kaniwa, and H Ogata, and N Aoyagi, and M Koibuchi, and T Shibazaki, and A Ejima, and S Takanashi, and H Kamiyama, and H Suzuki, and Y Hinohara
July 2009, Pakistan journal of pharmaceutical sciences,
N Kaniwa, and H Ogata, and N Aoyagi, and M Koibuchi, and T Shibazaki, and A Ejima, and S Takanashi, and H Kamiyama, and H Suzuki, and Y Hinohara
October 1979, Journal of pharmaceutical sciences,
N Kaniwa, and H Ogata, and N Aoyagi, and M Koibuchi, and T Shibazaki, and A Ejima, and S Takanashi, and H Kamiyama, and H Suzuki, and Y Hinohara
September 1982, Journal of pharmaceutical sciences,
N Kaniwa, and H Ogata, and N Aoyagi, and M Koibuchi, and T Shibazaki, and A Ejima, and S Takanashi, and H Kamiyama, and H Suzuki, and Y Hinohara
September 2014, European journal of drug metabolism and pharmacokinetics,
N Kaniwa, and H Ogata, and N Aoyagi, and M Koibuchi, and T Shibazaki, and A Ejima, and S Takanashi, and H Kamiyama, and H Suzuki, and Y Hinohara
September 1978, Journal of pharmaceutical sciences,
N Kaniwa, and H Ogata, and N Aoyagi, and M Koibuchi, and T Shibazaki, and A Ejima, and S Takanashi, and H Kamiyama, and H Suzuki, and Y Hinohara
June 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Copied contents to your clipboard!